Comparative analysis of financial toxicity between SARS-CoV-2 infection and common comorbidities
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0309116 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift PLOS ONE, 2024. Verfasst von Han Su und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, Vanderbilt University, Nashville, TN, United States of America. Hauptthemen laut MEDLINE: COVID-19, Comorbidity, SARS-CoV-2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Financial toxicity is common in individuals with COVID-19 and Long COVID. However, the extent of financial toxicity experienced, in comparison to other common comorbidities, is uncertain. Contributing factors exacerbating financial challenges in Long COVID are also unclear. These knowledge gaps are addressed via a cross-sectional analysis utilizing data from the 2022 National Health Interview Survey (NHIS), a representative sample drawn from the United States. COVID-19 cases were identified through self-reported positive testing or physician diagnoses. Long COVID was defined as experiencing COVID-19-related symptoms for more than three months. Comorbidity was assessed based on self-reported diagnoses of ten doctor-diagnosed conditions (Yes/No). Financial toxicity was defined as having difficulty paying medical bills, cost-related medication nonadherence, delaying healthcare due to cost, and/or not obtained healthcare due to cost. A total of 27,492 NHIS 2022 respondents were included in our analysis, representing 253 million U.S. adults. In multivariable logistic regression models, adults with Long COVID (excluding respondents with COVID-19 but not Long COVID), showed increased financial toxicity compared to those with other comorbidities, such as epilepsy (OR [95% CI]: 1.69 [1.22, 2.33]), dementia (1.51 [1.01, 2.25]), cancer (1.43 [1.19, 1.71]) or respiratory/cardiovascular conditions (1.18 [1.00, 1.40]/1.23 [1.02, 1.47]). Long COVID-related financial toxicity was associated with female sex, age
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Nursing, Vanderbilt University, Nashville, TN, United States of America.
- School of Nursing, University of Washington, Seattle, WA, United States of America.
- Department of Radiation Oncology, School of Medicine, University of Washington, Seattle, WA, United States of America.
- Division of Trauma, Emergency General Surgery and Surgical Critical Care, Vanderbilt University Medical Center, Nashville, TN, United States of America.
- Critical Illness, Brain Dysfunction and Survivorship Center, Vanderbilt University Medical, Nashville, TN, United States of America.
- Department of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
ORCID-Profile: Han Su
Zitieren
APA
Su, H., Thompson, H. J., Figuracion, K. C., Patel, M. B., & Needham, D. M. (2024). Comparative analysis of financial toxicity between SARS-CoV-2 infection and common comorbidities. PLOS ONE. https://doi.org/10.1371/journal.pone.0309116
Vancouver
Su H, Thompson HJ, Figuracion KC, Patel MB, Needham DM. Comparative analysis of financial toxicity between SARS-CoV-2 infection and common comorbidities. PLOS ONE. 2024. doi:10.1371/journal.pone.0309116
BibTeX
@article{Su2024,
author = {Su, Han and Thompson, Hilaire J and Figuracion, Karl Cristie and Patel, Mayur Bipin and Needham, Dale M},
title = {Comparative analysis of financial toxicity between SARS-CoV-2 infection and common comorbidities},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0309116}
}
EUVIMED